Candriam S.C.A. Bridge Bio Pharma, Inc. Transaction History

Candriam S.C.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$27.35 - $40.45 $2.22 Million - $3.28 Million	81,000 Added 27.09%	380,000 $11.7 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $1.3 Million - $2.37 Million	54,000 Added 22.04%	299,000 $12.1 Million
Q3 2023 Nov 13, 2023	SELL	$16.89 - $35.01 $675,600 - $1.4 Million	-40,000 Reduced 14.04%	245,000 $6.46 Million
Q1 2023 May 12, 2023	BUY	$7.17 - $18.55 $1.35 Million - $3.5 Million	188,756 Added 196.12%	285,000 $4.73 Million
Q4 2022 Feb 13, 2023	BUY	$6.74 - $11.52 $3,161 - $5,402	469 Added 0.49%	96,244 $733,000
Q3 2022 Nov 10, 2022	SELL	$7.94 - $12.36 $2.43 Million - $3.78 Million	-306,137 Reduced 76.17%	95,775 $952,000
Q4 2021 Feb 10, 2022	SELL	$11.38 - $53.41 $607,384 - $2.85 Million	-53,373 Reduced 11.72%	401,912 $6.7 Million
Q2 2021 Jul 20, 2021	BUY	$46.47 - $63.93 $21.2 Million - $29.1 Million	455,285 New	455,285 $27.8 Million

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.23B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.